Jul 7, 2026 04:31PM
Jun 4, 2026 06:42AM
May 27, 2026 07:00AM
May 11, 2026 07:13AM
May 6, 2026 04:03PM
May 4, 2026 08:02AM
May 1, 2026 04:36PM Vanda launches motion sickness drug NEREUS after 40-year gap
Apr 9, 2026 11:03AM
Apr 9, 2026 06:42AM
Apr 8, 2026 04:45PM
Mar 27, 2026 11:24AM
Mar 5, 2026 06:03AM
Mar 3, 2026 08:03AM
Feb 25, 2026 07:19AM FDA accepts Vanda's drug application for rare skin disorder treatment
Feb 23, 2026 10:38AM
Feb 23, 2026 06:36AM
Feb 23, 2026 05:19AM
Feb 20, 2026 04:22PM
Feb 12, 2026 07:21AM
Feb 11, 2026 04:03PM
Jan 8, 2026 07:01AM FDA rejects Vanda's HETLIOZ application for jet lag disorder
Jan 5, 2026 06:41AM
Dec 31, 2025 03:12PM
Dec 31, 2025 10:13AM
Dec 31, 2025 04:25AM
Dec 17, 2025 07:30AM
Dec 15, 2025 07:01AM
Dec 4, 2025 04:22PM FDA lifts clinical hold on Vanda's motion sickness drug tradipitant
Dec 1, 2025 06:35AM
Nov 28, 2025 07:00AM
Nov 5, 2025 02:42AM
Oct 29, 2025 04:05PM
Oct 28, 2025 03:07PM
Oct 2, 2025 06:45AM
Oct 1, 2025 05:03PM Vanda Pharmaceuticals reaches dispute resolution framework with FDA
Sep 25, 2025 08:03AM
Aug 28, 2025 07:00AM
Aug 21, 2025 04:40PM
Aug 21, 2025 06:36AM
Aug 18, 2025 07:01AM
Jul 31, 2025 07:46AM
May 14, 2025 09:03AM Cantor Fitzgerald Reiterates Overweight Rating on Vanda Pharmaceuticals (VNDA)
May 7, 2025 04:12PM
May 5, 2025 08:00AM
Apr 23, 2025 03:57PM
Mar 31, 2025 08:00AM
Mar 19, 2025 06:44AM
Mar 13, 2025 06:58AM
Feb 24, 2025 07:06AM Vanda Pharmaceuticals (VNDA) announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S"
Feb 18, 2025 06:44AM

425,763 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All